Review



ivis spectrum ct model 128201  (Revvity)


Bioz Verified Symbol Revvity is a verified supplier
Bioz Manufacturer Symbol Revvity manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Revvity ivis spectrum ct model 128201
    Ivis Spectrum Ct Model 128201, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 37397 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivis+spectrum+model/IVIS+optical+imaging+platform/pm41672263-76-6-10
    Average 96 stars, based on 37397 article reviews
    ivis spectrum ct model 128201 - by Bioz Stars, 2026-09
    96/100 stars

    Images

    Related Articles

    In Vivo:

    Article Title: Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation
    Article Snippet: .. Subsequently, the gathered lymph nodes underwent scrutiny employing an innovative in vivo optical imaging mechanism, notably the IVIS Spectrum model from PerkinElmer, which facilitated the detection and quantification of the fluorescent emissions from the ICG‐marked components within these nodes and additional organs. ..

    Article Title: Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation
    Article Snippet: .. Subsequently, the gathered lymph nodes underwent scrutiny employing an innovative in vivo optical imaging mechanism, notably the IVIS Spectrum model from PerkinElmer, which facilitated the detection and quantification of the fluorescent emissions from the ICG-marked components within these nodes and additional organs. ..

    Optical Imaging:

    Article Title: Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation
    Article Snippet: .. Subsequently, the gathered lymph nodes underwent scrutiny employing an innovative in vivo optical imaging mechanism, notably the IVIS Spectrum model from PerkinElmer, which facilitated the detection and quantification of the fluorescent emissions from the ICG‐marked components within these nodes and additional organs. ..

    Article Title: Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation
    Article Snippet: .. Subsequently, the gathered lymph nodes underwent scrutiny employing an innovative in vivo optical imaging mechanism, notably the IVIS Spectrum model from PerkinElmer, which facilitated the detection and quantification of the fluorescent emissions from the ICG-marked components within these nodes and additional organs. ..



    Similar Products

    ivis spectrum ct model 128201  (Revvity)
    96
    Revvity ivis spectrum ct model 128201
    Ivis Spectrum Ct Model 128201, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivis+spectrum+model/IVIS+optical+imaging+platform/pm41672263-76-6-10
    Average 96 stars, based on 1 article reviews
    ivis spectrum ct model 128201 - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    ivis spectrum model  (Revvity)
    96
    Revvity ivis spectrum model
    nECTs combined with FMD for lymph node targeting and stimulation of adaptive immune responses in vivo. (A) Ex vivo <t>IVIS</t> imaging and (B) quantitative analysis of fluorescence intensity in draining lymph nodes after treatment with free ICG or ICG‐labelled BnECTs for 24 h. (C) Schematic illustration of antigen‐specific T cell response stimulation using nECTs with FMD treatment. (D) Flow cytometry data and (E) quantitative analysis of IFN‐γ‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. (F) Quantitative analysis of TNF‐α‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. Quantitative analysis of (G) IFN‐γ, (H) TNF‐α, (I) IL‐6, and (J) IL‐12p70 in the serum of the BALB/C mice with various treatments. Error bars represent ± s.d. ( n = 4). Statistical significance was assessed by one‐way ANOVA with Tukey test. * p < 0.05, ** p < 0.01.
    Ivis Spectrum Model, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivis+spectrum+model/IVIS+optical+imaging+platform/pmc12752548-333-17-21
    Average 96 stars, based on 1 article reviews
    ivis spectrum model - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    xenogen live bioluminescence imaging system with an ivis spectrum optical imaging device (model lb 983 nc100)  (Berthold Technologies)
    90
    Berthold Technologies xenogen live bioluminescence imaging system with an ivis spectrum optical imaging device (model lb 983 nc100)
    nECTs combined with FMD for lymph node targeting and stimulation of adaptive immune responses in vivo. (A) Ex vivo <t>IVIS</t> imaging and (B) quantitative analysis of fluorescence intensity in draining lymph nodes after treatment with free ICG or ICG‐labelled BnECTs for 24 h. (C) Schematic illustration of antigen‐specific T cell response stimulation using nECTs with FMD treatment. (D) Flow cytometry data and (E) quantitative analysis of IFN‐γ‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. (F) Quantitative analysis of TNF‐α‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. Quantitative analysis of (G) IFN‐γ, (H) TNF‐α, (I) IL‐6, and (J) IL‐12p70 in the serum of the BALB/C mice with various treatments. Error bars represent ± s.d. ( n = 4). Statistical significance was assessed by one‐way ANOVA with Tukey test. * p < 0.05, ** p < 0.01.
    Xenogen Live Bioluminescence Imaging System With An Ivis Spectrum Optical Imaging Device (Model Lb 983 Nc100), supplied by Berthold Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ivis+spectrum+model/nightowl+lb981+nc100+system/10__1016_slash_j__cej__2024__158616-141-6-24
    Average 90 stars, based on 1 article reviews
    xenogen live bioluminescence imaging system with an ivis spectrum optical imaging device (model lb 983 nc100) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    nECTs combined with FMD for lymph node targeting and stimulation of adaptive immune responses in vivo. (A) Ex vivo IVIS imaging and (B) quantitative analysis of fluorescence intensity in draining lymph nodes after treatment with free ICG or ICG‐labelled BnECTs for 24 h. (C) Schematic illustration of antigen‐specific T cell response stimulation using nECTs with FMD treatment. (D) Flow cytometry data and (E) quantitative analysis of IFN‐γ‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. (F) Quantitative analysis of TNF‐α‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. Quantitative analysis of (G) IFN‐γ, (H) TNF‐α, (I) IL‐6, and (J) IL‐12p70 in the serum of the BALB/C mice with various treatments. Error bars represent ± s.d. ( n = 4). Statistical significance was assessed by one‐way ANOVA with Tukey test. * p < 0.05, ** p < 0.01.

    Journal: Exploration

    Article Title: Personalized Cancer Immunotherapy Boosted by cGAS‐STING‐Targeted Nanovaccines in Combination With Nutrient Modulation

    doi: 10.1002/EXP.20240183

    Figure Lengend Snippet: nECTs combined with FMD for lymph node targeting and stimulation of adaptive immune responses in vivo. (A) Ex vivo IVIS imaging and (B) quantitative analysis of fluorescence intensity in draining lymph nodes after treatment with free ICG or ICG‐labelled BnECTs for 24 h. (C) Schematic illustration of antigen‐specific T cell response stimulation using nECTs with FMD treatment. (D) Flow cytometry data and (E) quantitative analysis of IFN‐γ‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. (F) Quantitative analysis of TNF‐α‐positive cells in CD3 + CD8 + T cells in lymph nodes on Day 22 post‐immunization of BALB/C mice. Quantitative analysis of (G) IFN‐γ, (H) TNF‐α, (I) IL‐6, and (J) IL‐12p70 in the serum of the BALB/C mice with various treatments. Error bars represent ± s.d. ( n = 4). Statistical significance was assessed by one‐way ANOVA with Tukey test. * p < 0.05, ** p < 0.01.

    Article Snippet: Subsequently, the gathered lymph nodes underwent scrutiny employing an innovative in vivo optical imaging mechanism, notably the IVIS Spectrum model from PerkinElmer, which facilitated the detection and quantification of the fluorescent emissions from the ICG‐marked components within these nodes and additional organs.

    Techniques: In Vivo, Ex Vivo, Imaging, Fluorescence, Flow Cytometry